vs

Side-by-side financial comparison of GERON CORP (GERN) and Lifeway Foods, Inc. (LWAY). Click either name above to swap in a different company.

Lifeway Foods, Inc. is the larger business by last-quarter revenue ($55.4M vs $47.2M, roughly 1.2× GERON CORP). Lifeway Foods, Inc. runs the higher net margin — 4.6% vs -39.0%, a 43.6% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 18.0%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 11.4%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.

GERN vs LWAY — Head-to-Head

Bigger by revenue
LWAY
LWAY
1.2× larger
LWAY
$55.4M
$47.2M
GERN
Growing faster (revenue YoY)
GERN
GERN
+49.1% gap
GERN
67.1%
18.0%
LWAY
Higher net margin
LWAY
LWAY
43.6% more per $
LWAY
4.6%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
11.4%
LWAY

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GERN
GERN
LWAY
LWAY
Revenue
$47.2M
$55.4M
Net Profit
$-18.4M
$2.5M
Gross Margin
27.8%
Operating Margin
-29.4%
6.8%
Net Margin
-39.0%
4.6%
Revenue YoY
67.1%
18.0%
Net Profit YoY
30.3%
1688.1%
EPS (diluted)
$-0.03
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
LWAY
LWAY
Q4 25
$55.4M
Q3 25
$47.2M
$57.1M
Q2 25
$49.0M
$53.9M
Q1 25
$39.6M
$46.1M
Q4 24
$46.9M
Q3 24
$28.3M
$46.1M
Q2 24
$882.0K
$49.2M
Q1 24
$304.0K
$44.6M
Net Profit
GERN
GERN
LWAY
LWAY
Q4 25
$2.5M
Q3 25
$-18.4M
$3.5M
Q2 25
$-16.4M
$4.2M
Q1 25
$-19.8M
$3.5M
Q4 24
$-160.0K
Q3 24
$-26.4M
$3.0M
Q2 24
$-67.4M
$3.8M
Q1 24
$-55.4M
$2.4M
Gross Margin
GERN
GERN
LWAY
LWAY
Q4 25
27.8%
Q3 25
28.7%
Q2 25
28.6%
Q1 25
23.9%
Q4 24
25.3%
Q3 24
25.7%
Q2 24
27.0%
Q1 24
25.8%
Operating Margin
GERN
GERN
LWAY
LWAY
Q4 25
6.8%
Q3 25
-29.4%
8.8%
Q2 25
-25.4%
10.8%
Q1 25
-42.2%
3.4%
Q4 24
1.5%
Q3 24
-99.8%
9.1%
Q2 24
-7860.9%
11.0%
Q1 24
-18465.1%
8.0%
Net Margin
GERN
GERN
LWAY
LWAY
Q4 25
4.6%
Q3 25
-39.0%
6.2%
Q2 25
-33.4%
7.9%
Q1 25
-50.1%
7.7%
Q4 24
-0.3%
Q3 24
-93.5%
6.5%
Q2 24
-7639.8%
7.7%
Q1 24
-18220.4%
5.4%
EPS (diluted)
GERN
GERN
LWAY
LWAY
Q4 25
$0.15
Q3 25
$-0.03
$0.23
Q2 25
$-0.02
$0.28
Q1 25
$-0.03
$0.23
Q4 24
$0.00
Q3 24
$-0.04
$0.19
Q2 24
$-0.10
$0.25
Q1 24
$-0.09
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
LWAY
LWAY
Cash + ST InvestmentsLiquidity on hand
$78.1M
$5.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$248.7M
$85.8M
Total Assets
$567.4M
$105.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
LWAY
LWAY
Q4 25
$5.6M
Q3 25
$78.1M
$23.0M
Q2 25
$77.7M
$21.2M
Q1 25
$83.7M
$19.4M
Q4 24
$16.7M
Q3 24
$60.3M
$20.6M
Q2 24
$116.9M
$14.6M
Q1 24
$189.8M
$12.0M
Total Debt
GERN
GERN
LWAY
LWAY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$2.5M
Stockholders' Equity
GERN
GERN
LWAY
LWAY
Q4 25
$85.8M
Q3 25
$248.7M
$82.8M
Q2 25
$259.5M
$78.7M
Q1 25
$268.2M
$74.2M
Q4 24
$71.9M
Q3 24
$292.3M
$71.5M
Q2 24
$306.7M
$68.0M
Q1 24
$344.9M
$63.5M
Total Assets
GERN
GERN
LWAY
LWAY
Q4 25
$105.6M
Q3 25
$567.4M
$109.5M
Q2 25
$555.2M
$98.3M
Q1 25
$562.5M
$93.7M
Q4 24
$90.5M
Q3 24
$444.9M
$91.3M
Q2 24
$449.4M
$84.9M
Q1 24
$482.1M
$82.8M
Debt / Equity
GERN
GERN
LWAY
LWAY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
LWAY
LWAY
Operating Cash FlowLast quarter
$-13.6M
$267.0K
Free Cash FlowOCF − Capex
$-17.4M
FCF MarginFCF / Revenue
-31.5%
Capex IntensityCapex / Revenue
31.9%
Cash ConversionOCF / Net Profit
0.11×
TTM Free Cash FlowTrailing 4 quarters
$-16.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
LWAY
LWAY
Q4 25
$267.0K
Q3 25
$-13.6M
$6.9M
Q2 25
$-27.4M
$3.9M
Q1 25
$-48.0M
$-150.0K
Q4 24
$-2.6M
Q3 24
$-58.9M
$7.5M
Q2 24
$-53.5M
$6.5M
Q1 24
$-62.3M
$1.5M
Free Cash Flow
GERN
GERN
LWAY
LWAY
Q4 25
$-17.4M
Q3 25
$1.8M
Q2 25
$1.6M
Q1 25
$-2.4M
Q4 24
$-3.8M
Q3 24
$5.9M
Q2 24
$-53.7M
$5.1M
Q1 24
$-62.9M
$-923.0K
FCF Margin
GERN
GERN
LWAY
LWAY
Q4 25
-31.5%
Q3 25
3.1%
Q2 25
3.0%
Q1 25
-5.1%
Q4 24
-8.2%
Q3 24
12.8%
Q2 24
-6086.6%
10.4%
Q1 24
-20680.3%
-2.1%
Capex Intensity
GERN
GERN
LWAY
LWAY
Q4 25
31.9%
Q3 25
9.0%
Q2 25
4.3%
Q1 25
4.8%
Q4 24
2.7%
Q3 24
0.0%
3.3%
Q2 24
23.4%
2.9%
Q1 24
202.3%
5.5%
Cash Conversion
GERN
GERN
LWAY
LWAY
Q4 25
0.11×
Q3 25
1.96×
Q2 25
0.92×
Q1 25
-0.04×
Q4 24
Q3 24
2.50×
Q2 24
1.73×
Q1 24
0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GERN
GERN

Segment breakdown not available.

LWAY
LWAY

Drinkable Kefirotherthan Pro Bugs$47.8M86%
Cheese$4.7M8%
Cream And Other$1.7M3%
Other$1.2M2%

Related Comparisons